1. Início
  2. Faculdade de Medicina - FM
  3. Departamento de Cardiopneumologia - FM/MCP
  4. Artigos e Materiais de Revistas Científicas - FM/MCP
Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/45897
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorHAJJAR, Ludhmila Abrahao-
dc.contributor.authorFONSECA, Silvia Moulin Ribeiro-
dc.contributor.authorMACHADO, Theuran Inahja Vicente-
dc.date.accessioned2022-04-19T12:57:03Z-
dc.date.available2022-04-19T12:57:03Z-
dc.date.issued2021-
dc.identifier.citationFRONTIERS IN CARDIOVASCULAR MEDICINE, v.8, article ID 590768, 5p, 2021-
dc.identifier.issn2297-055X-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/45897-
dc.description.abstractCancer patients have a higher risk of atrial fibrillation (AF) than general population, the pathophysiology mechanisms involves the pro inflammatory status of immune system in these patients and the exacerbated inflammatory response to cancer treatment and surgeries. Adequate management and prophylaxis for its occurrence are important and reduce morbidity and mortality in this population. There is a challenge in AF related to cancer to predict thromboembolic and bleeding risk in these patients, once standard stroke and hemorrhagic prediction scores are not validated for them. It is used CHA2DS2-VASc and HAS-BLED scores, the same as used in general population. In this review, we demonstrate correlated mechanisms to occurrence AF in cancer patients as well as therapeutic challenges in this population.eng
dc.language.isoeng-
dc.publisherFRONTIERS MEDIA SAeng
dc.relation.ispartofFrontiers in Cardiovascular Medicine-
dc.rightsopenAccesseng
dc.subjectatrial fibrillationeng
dc.subjectcancereng
dc.subjectanticoagulationeng
dc.subjectcardiotoxicityeng
dc.subjectdrug-drug interactioneng
dc.subject.otheranticoagulationeng
dc.subject.othertherapyeng
dc.titleAtrial Fibrillation and Cancereng
dc.typearticleeng
dc.rights.holderCopyright FRONTIERS MEDIA SAeng
dc.identifier.doi10.3389/fcvm.2021.590768-
dc.identifier.pmid34336939-
dc.subject.wosCardiac & Cardiovascular Systemseng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
hcfmusp.description.articlenumber590768-
hcfmusp.description.volume8-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000753658000001-
hcfmusp.origem.id2-s2.0-85127037628-
hcfmusp.publisher.cityLAUSANNEeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.referenceAlexandre J, 2018, PHARMACOL THERAPEUT, V189, P89, DOI 10.1016/j.pharmthera.2018.04.009eng
hcfmusp.relation.referenceCannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454eng
hcfmusp.relation.referenceCheng WL, 2016, INT J CARDIOL, V219, P186, DOI 10.1016/j.ijcard.2016.06.009eng
hcfmusp.relation.referenceChu G, 2019, BLOOD REV, V35, P59, DOI 10.1016/j.blre.2019.03.005eng
hcfmusp.relation.referenceFarmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026eng
hcfmusp.relation.referenceFitzpatrick T, 2017, THROMB RES, V155, P101, DOI 10.1016/j.thromres.2017.05.006eng
hcfmusp.relation.referenceGibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594eng
hcfmusp.relation.referenceGoriacko P, 2018, EUR J HAEMATOL, V100, P488, DOI 10.1111/ejh.13045eng
hcfmusp.relation.referenceLopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083eng
hcfmusp.relation.referenceLopez-Fernandez T, 2019, REV ESP CARDIOL, V72, P749, DOI 10.1016/j.rec.2019.03.019eng
hcfmusp.relation.referenceMelloni C, 2017, EUR HEART J, V3, P192, DOI 10.1093/ehjqcco/qcx004eng
hcfmusp.relation.referenceMery B, 2017, INT J CARDIOL, V240, P196, DOI 10.1016/j.ijcard.2017.03.132eng
hcfmusp.relation.referenceMosarla RC, 2019, J AM COLL CARDIOL, V73, P1336, DOI 10.1016/j.jacc.2019.01.017eng
hcfmusp.relation.referenceQamar A, 2018, J AM COLL CARDIOL, V71, P2162, DOI 10.1016/j.jacc.2018.03.023eng
hcfmusp.relation.referenceVedovati MC, 2018, INT J CARDIOL, V269, P152, DOI 10.1016/j.ijcard.2018.07.138eng
dc.description.indexPubMedeng
hcfmusp.citation.scopus11-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/08
LIM/08 - Laboratório de Anestesiologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_HAJJAR_Atrial_Fibrillation_and_Cancer_2021.PDFpublishedVersion (English)800.81 kBAdobe PDFThumbnail
View/Open
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.